Englander Institute for Precision Medicine

Generation of transmitochondrial cybrids in cancer cells.

TitleGeneration of transmitochondrial cybrids in cancer cells.
Publication TypeJournal Article
Year of Publication2024
AuthorsSoler-Agesta R, Ripollés-Yuba C, Marco-Brualla J, Moreno-Loshuertos R, Sato A, Beltrán-Visiedo M, Galluzzi L, Anel A
JournalMethods Cell Biol
Volume189
Pagination23-40
Date Published2024
ISSN0091-679X
KeywordsCell Line, Tumor, DNA, Mitochondrial, Genome, Mitochondrial, Humans, Hybrid Cells, Mitochondria, Neoplasms
Abstract

At odds with historical views suggesting that mitochondrial functions are largely dispensable for cancer cells, it is now clear that mitochondria have a major impact on malignant transformation, tumor progression and response to treatment. Mitochondria are indeed critical for neoplastic cells not only as an abundant source of ATP and other metabolic intermediates, but also as gatekeepers of apoptotic cell death and inflammation. Interestingly, while mitochondrial components are mostly encoded by nuclear genes, mitochondria contain a small, circular genome that codes for a few mitochondrial proteins, ribosomal RNAs and transfer RNAs. Here, we describe a straightforward method to generate transmitochondrial cybrids, i.e., cancer cells depleted of their mitochondrial DNA and reconstituted with intact mitochondria from another cellular source. Once established, transmitochondrial cybrids can be stably propagated and are valuable to dissect the specific impact of the mitochondrial genome on cancer cell functions.

DOI10.1016/bs.mcb.2024.05.010
Alternate JournalMethods Cell Biol
PubMed ID39393884

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021